Member Content

Small Cap Biotech Attracts Bullish Long Term Bets on Cancer Drug

by Joe Kunkle | Jul 13, 2021

Nektar Therapeutics (NKTR) shares forming a multi-week base above the $16.35 level and RSI trending higher, a positive sign. NKTR on 7/13 with a buyer of 1000 December 2022 $20 calls for $5.30 and follows a 6/15 buyer of 2575 December 2022 $17 calls ...

Please login to continue reading this article.

Options Hawk Max

$300 | 30 days

Options Hawk Trading Hub Live Chat
Hawk’s Market Blitz
Spotlight Trades (2 Per Week)
Market Recap
Weekly Earnings Snapshots
Live Mock Portfolio
1 on 1 Access
Hawk’s Trader Toolbox
Street Research
OptionsHawk Research
Daily Options Radar
OptionHawk’s Weekly Radar Report
Options Hawk Market Outlook Access
Daily Earnings Grid
Weekly and Monthly OpEx Sheets
Notable Options Database
OptionsHawk Quarterly Market Brief

More About this Plan

Options Hawk Elite

$149 | 30 days

Hawk’s Market Blitz
Spotlight Trades (2 Per Week)
Market Recap
Weekly Earnings Snapshots
OptionsHawk Research
Daily Options Radar
OptionHawk’s Weekly Radar Report
Options Hawk Market Outlook Access
Daily Earnings Grid
OptionsHawk Quarterly Market Brief

More About this Plan